The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR). In CKD, ongoing inflammation and abnormal blood vessel growth can damage these small vessels, leading to heart stiffness and weaker heart function. A kidney transplant offers a unique chance to study how better kidney function and reduced inflammation affect heart health. The observational RESTORE study (Impact of Renal Transplant on Coronary Microvascular Function in Patients with Advanced CKD) will measure heart blood flow and function before and after transplant. The study will test whether: 1. Inflammation and abnormal vessel growth are linked to poor heart blood flow and heart function in CKD. 2. Kidney transplant improves heart blood flow and function. 3. Lower inflammation after transplant leads to better heart health. By understanding how kidney disease and inflammation affect the heart-and how transplant may reverse these effects-this research could help guide future treatments to better protect heart health in patients with CKD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Renal transplant candidate on the waitlist

• Age greater or equal to 45 years, or if 18-44 years of age on dialysis for 5 years or more

Locations
United States
Massachusetts
Brigham and Women's Hospital
RECRUITING
Boston
Contact Information
Primary
Daniel M Huck, MD, MPH
dhuck@bwh.harvard.edu
8573074000
Time Frame
Start Date: 2023-03-10
Estimated Completion Date: 2030-07
Participants
Target number of participants: 80
Treatments
Transplant Arm
Patients followed before and after transplant
Waitlist Control Arm
Patients followed before transplant while on the waitlist
Sponsors
Leads: Brigham and Women's Hospital
Collaborators: American Heart Association (AHA), National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov